Guaiacol salicylateCAS# 87-16-1 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 87-16-1 | SDF | Download SDF |
PubChem ID | 66596 | Appearance | Powder |
Formula | C14H12O4 | M.Wt | 244.25 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | 2-Methoxyphenyl salicylate;Guaiacol salol | ||
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2-methoxyphenyl) 2-hydroxybenzoate | ||
SMILES | COC1=CC=CC=C1OC(=O)C2=CC=CC=C2O | ||
Standard InChIKey | APMWEQQELZTXTL-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C14H12O4/c1-17-12-8-4-5-9-13(12)18-14(16)10-6-2-3-7-11(10)15/h2-9,15H,1H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Guaiacol salicylate Dilution Calculator
Guaiacol salicylate Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.0942 mL | 20.4708 mL | 40.9417 mL | 81.8833 mL | 102.3541 mL |
5 mM | 0.8188 mL | 4.0942 mL | 8.1883 mL | 16.3767 mL | 20.4708 mL |
10 mM | 0.4094 mL | 2.0471 mL | 4.0942 mL | 8.1883 mL | 10.2354 mL |
50 mM | 0.0819 mL | 0.4094 mL | 0.8188 mL | 1.6377 mL | 2.0471 mL |
100 mM | 0.0409 mL | 0.2047 mL | 0.4094 mL | 0.8188 mL | 1.0235 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Eburicol
Catalog No.:BCN4252
CAS No.:6890-88-6
- Otonecine
Catalog No.:BCN2009
CAS No.:6887-34-9
- 8-O-Methylretusin-7-O-beta-D-glucopyranoside
Catalog No.:BCN7899
CAS No.:68862-13-5
- HMP Linker
Catalog No.:BCC2832
CAS No.:68858-21-9
- Fmoc-Val-OH
Catalog No.:BCC3570
CAS No.:68858-20-8
- Boc-D-Tyr(Me)-OH
Catalog No.:BCC2597
CAS No.:68856-96-2
- Astemizole
Catalog No.:BCC7691
CAS No.:68844-77-9
- Xanthohumol L
Catalog No.:BCN8017
CAS No.:688360-15-8
- Xanthohumol I
Catalog No.:BCN8016
CAS No.:688360-06-7
- IWP 12
Catalog No.:BCC5622
CAS No.:688353-45-9
- 4-Epi-isoinuviscolide
Catalog No.:BCN4251
CAS No.:68832-39-3
- D-Prolinol(oil)
Catalog No.:BCC2708
CAS No.:68832-13-3
- H-D-Glu-OH
Catalog No.:BCC2936
CAS No.:6893-26-1
- Kahweol
Catalog No.:BCC9006
CAS No.:6894-43-5
- SKF 91488 dihydrochloride
Catalog No.:BCC6675
CAS No.:68941-21-9
- Mulberrofuran A
Catalog No.:BCN3677
CAS No.:68978-04-1
- Uncarine A
Catalog No.:BCN7767
CAS No.:6899-73-6
- Quinacrine 2HCl
Catalog No.:BCC4709
CAS No.:69-05-6
- Chlorpromazine HCl
Catalog No.:BCC4460
CAS No.:69-09-0
- Ampicillin
Catalog No.:BCC1199
CAS No.:69-52-3
- Penicillin G Sodium
Catalog No.:BCC4638
CAS No.:69-57-8
- D-Mannitol
Catalog No.:BCN2205
CAS No.:69-65-8
- Salicylic acid
Catalog No.:BCC4109
CAS No.:69-72-7
- Cytarabine hydrochloride
Catalog No.:BCC4116
CAS No.:69-74-9
[The physiologic disposition and pharmacokinetics of guaiacol acetylsalicylate in rats].[Pubmed:2092574]
Yao Xue Xue Bao. 1990;25(9):664-9.
Guaiacol acetylsalicylate (GASL) has been shown to possess significant anti-inflammatory, antipyretic and expectorant activities and has been used clinically in chronic bronchitis with fairly good results. In the present work, the absorption, distribution and excretion of metabolites of the drug were studied in rats using quantitative TLC scanning technique. GASL was shown to be unstable in rat gastrointestinal tract and Guaiacol salicylate (GSLT) and salicylic acid (SLA) were found in plasma. The plasma SLA concentration-time curve obtained after oral administration of GASL to rats was shown to fit a one compartment open model with the following pharmacokinetic parameters: T1/2ka = 1.25 h, T1/2ke = 3.28 h, ka = 0.5554/h, ke = 0.2111/h, Tmax = 3.02 h, Cmax = 331.46 micrograms/ml, AUC = 2832.93 micrograms/ml.h The SLA concentration was found to be high in muscle, moderate in spleen, testicle, kidney, lung, plasma, heart and liver and low in brain. The GSLT concentration was found to be low in plasma and organs. Within 24 h following ig administration of GASL the total SLA excreted in urine and feces was 10.9 and 0.41 of the GASL dose, respectively.